Kerr WT, Ngo LY, Zhu L, Patten A, et al. Time to prerandomization seizure count design sufficiently assessed the safety and tolerability of perampanel for the treatment of focal seizures. Epilepsia 2025;66:3207-3218.
PMID: 40372283